Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2773
Source ID: NCT00306072
Associated Drug: Nutritional Herbal Extract From Salacia Oblonga
Title: Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic Response in Patients With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus
Interventions: DRUG: nutritional herbal extract from Salacia oblonga
Outcome Measures: Primary: The primary variable to be measured was positive AUC (0-180 minutes) for plasma glucose. | Secondary: The secondary variables to be measured were:|· Positive AUC (0 to 120 minutes) for plasma and serum glucose and positive AUC (0 to 180 minutes) for serum glucose|· Adjusted peak value for plasma and serum glucose|· Adjusted peak value for serum insulin|· Positive AUC 0-180 (0 to 120) minutes for serum insulin
Sponsor/Collaborators: Sponsor: Ross Products
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE1|PHASE2
Enrollment: 82
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2005-06
Completion Date: 2005-09
Results First Posted:
Last Update Posted: 2010-01-27
Locations: Radiant Research, Edina, Minnesota, 55435, United States|Radiant Research, Cincinnati, Ohio, 45236, United States
URL: https://clinicaltrials.gov/show/NCT00306072